全文获取类型
收费全文 | 116885篇 |
免费 | 11268篇 |
国内免费 | 9100篇 |
专业分类
耳鼻咽喉 | 986篇 |
儿科学 | 1095篇 |
妇产科学 | 1153篇 |
基础医学 | 13877篇 |
口腔科学 | 1940篇 |
临床医学 | 15773篇 |
内科学 | 17498篇 |
皮肤病学 | 1209篇 |
神经病学 | 6238篇 |
特种医学 | 4278篇 |
外国民族医学 | 78篇 |
外科学 | 11951篇 |
综合类 | 20725篇 |
现状与发展 | 41篇 |
一般理论 | 6篇 |
预防医学 | 7927篇 |
眼科学 | 3352篇 |
药学 | 12205篇 |
95篇 | |
中国医学 | 7079篇 |
肿瘤学 | 9747篇 |
出版年
2024年 | 425篇 |
2023年 | 1979篇 |
2022年 | 4998篇 |
2021年 | 6355篇 |
2020年 | 4755篇 |
2019年 | 4012篇 |
2018年 | 4176篇 |
2017年 | 3709篇 |
2016年 | 3560篇 |
2015年 | 5442篇 |
2014年 | 6654篇 |
2013年 | 5849篇 |
2012年 | 8524篇 |
2011年 | 9412篇 |
2010年 | 5932篇 |
2009年 | 4673篇 |
2008年 | 6044篇 |
2007年 | 5983篇 |
2006年 | 5796篇 |
2005年 | 5864篇 |
2004年 | 3811篇 |
2003年 | 3497篇 |
2002年 | 3005篇 |
2001年 | 2662篇 |
2000年 | 2807篇 |
1999年 | 2998篇 |
1998年 | 1996篇 |
1997年 | 2016篇 |
1996年 | 1548篇 |
1995年 | 1472篇 |
1994年 | 1268篇 |
1993年 | 791篇 |
1992年 | 987篇 |
1991年 | 794篇 |
1990年 | 664篇 |
1989年 | 625篇 |
1988年 | 520篇 |
1987年 | 458篇 |
1986年 | 399篇 |
1985年 | 298篇 |
1984年 | 136篇 |
1983年 | 116篇 |
1982年 | 68篇 |
1981年 | 72篇 |
1980年 | 47篇 |
1979年 | 54篇 |
1974年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
比索洛尔改善充血性心衰心功能及心肌重塑的疗效观察 总被引:5,自引:1,他引:4
目的 观察比索洛尔 (bisoprolol)对充血性心衰心功能及心肌重塑的临床疗效 .方法 2 12例患者随机分为比索洛尔组和常规药物组 ,比索洛尔剂量起始量 0 .6 2 5 mg~1.2 5 0 mg,1次· d- 1 ,逐渐增加至最大剂量为 2 .5 mg~ 5 .0mg,1次· d- 1 .观察心功能、临床疗效、左室舒张末内径(L VEDD)、左室收缩末内径 (L VESD)、射血分数 (EF)、舒张早期 E峰流速 /舒张晚期 A峰流速 (VE/ VA) .结果 比索洛尔组与常规药物组比较 ,比索洛尔治疗 3m o后有效者(87.7% )高于常规药物组 (6 6 .0 % ) ,P <0 .0 5 ;冠心病(87.9% )和扩张型心肌病心衰 (91.9% )疗效明显好于常规药物组 (分别为 6 6 .7% ,6 7.4 % ) ;治疗 6 mo后重度心衰者疗效(90 .0 % )明显好于常规药物组 (6 5 .4 % ,P <0 .0 5 ) .治疗后比索洛尔组 L VESD[(44 .8± 3.9) m m vs(48.8± 4 .6 ) mm],EF[(40 .7± 7.5 ) % vs (35 .7± 5 .2 ) % ]优于常规药物组 (P<0 .0 1) ;L VEDD,VE/ VA也较治疗前有明显改善 .结论 比索洛尔改善充血性心力衰竭临床症状 ,促进心脏收缩、舒张功能恢复 ,部分逆转心肌重塑 . 相似文献
112.
113.
114.
Xiaoguang Chen Yi Li Lei Wang Mark Katakowski Lijie Zhang Jieli Chen Yongxian Xu Subhash C. Gautam Michael Chopp 《Neuropathology》2002,22(4):275-279
Intravenous administration of human bone marrow stromal cells (hMSCs) after middle cerebral artery occlusion (MCAo) in rats provides functional benefit. We tested the hypothesis that these functional benefits are derived in part from hMSC production of growth and trophic factors. Quantitative sandwich enzyme‐linked immunosorbent assay (ELISA) of hMSCs cultured with normal and MCAo brain extracts were performed. hMSCs cultured in supernatant derived from ischemic brain extracts increased production of brain‐derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). These neurotrophins and angiogenic growth factors increased in a post‐ischemia time‐dependent manner. The hMSC capacity to increase expression of growth and trophic factors may be the key to the benefit provided by transplanted hMSCs in the ischemic brain. 相似文献
115.
Platelet factor 4 ( PF4) is a negativehematopoietic factor.It can inhibit the prolifera-tion of endothelial cells and hematopoietic stem/progenitor cells,particularly megakaryoryocyticcells,reversibly[1] ,inhibit DNA synthesis,blockcell cycle progression during S phase and reducethe sensibility of normal hematopoietic stem/pro-genitor cells,but not some cancer or leukemia celllines,to cytotoxic drugs and ionizing radia-tion[2 - 3] ,and it also can cause a population in-crease of the stem cel… 相似文献
116.
目的探讨肥胖患者下腹部手术采用Joel—Cohen切口对预防非感染性切口裂开的临床效果。方法选择切口部位皮下脂肪层厚达4—5cm的妇产科手术患者90例,随机分为观察组44例,采用Joel—Cohen切口;对照组46例,采用下腹正中直切口。观察切口愈合和脂肪液化情况。结果观察组切口甲级愈合率显著高于对照组(P〈0.01);脂肪液化切口裂开率显著低于对照组(P〈0.05)。结论脂肪组织厚达4—5cm以上下腹部手术切口,采用Joel—Cohen切口可以减少脂肪液化,切口愈合显著优于下腹直切口,值得临床推广应用。 相似文献
117.
118.
Guerard W. Byrne Johannes M. Schirmer David N. Fass Sumeet S. Teotia Walter K. Kremers Hui Xu Bashoo Naziruddin Henry D. Tazelaar John S. Logan Christopher G. A. McGregor 《American journal of transplantation》2005,5(5):1011-1020
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded. 相似文献
119.
[目的]揭示青少年胸椎特发性侧凸患者椎管内脊髓的偏移,明确其变化趋势,并探讨其可能的发生机制和临床意义。[方法]本研究包括39名以右胸弯为主弯的青少年特发性脊柱侧凸(adolescent idiopathic scoliosis,AIS)患者。测量主胸弯节段内(T5-12)椎管内脊髓与凸凹侧椎弓根之间的距离,计算脊髓的偏移,揭示其变化趋势,并分析顶椎区脊髓偏移与主胸弯Cobb's角和顶椎相对偏移之间的相关性。[结果]在T5-12节段椎管内,脊髓与凸侧椎弓根之间的距离显著大于与凹侧椎弓根之间的距离(P〈0.05),即脊髓向凹侧椎弓根偏移,且以顶椎区最为显著,而逐渐向两侧端椎区递减。顶椎区脊髓偏移与主胸弯Cobb’s角和顶椎相对偏移存在显著的正相关(相关系数分别为0.631和0.546)。[结论]胸椎特发性脊柱侧凸患者存在侧凸节段椎管内脊髓偏移的现象,且以顶椎区最显著。研究结果提示脊髓偏移可能与脊椎偏移后凹侧脊神经的牵拉有关,而且凹侧置钉的风险高于凸侧。 相似文献
120.
Lin Bo Wang Jian Guo Shen Li Feng Dong Chao Yang Xu Wen Jun Chen Shu Duo Xie Xiang Yang Song Ning Dai Xiao Ming Yuan 《Journal of gastrointestinal surgery》2008,12(8):1359-1363
We previously reported that lymphatic mapping using isosulfan blue can be used to identify sentinel nodes (SNs). This study
was undertaken to evaluate the feasibility of using the SN technique in treating early gastric cancer and to explore its usefulness
for minimal invasive surgery. Twenty-three patients with early gastric cancer who underwent SN biopsy were retrospectively
evaluated. Based on SN evaluation, individualized surgery was performed in five patients with T1N0M0 gastric cancer. When
pathological examination of frozen sections revealed metastasis in SNs, we performed a standard D2 gastrectomy. Laparoscopic
local resection was applied when the SN biopsy was negative. Our results showed that the success rate with SN biopsy in early
gastric cancer was 100%, as were the accuracy, sensitivity, and specificity. All five patients with early gastric cancer had
SNs negative for metastases both by frozen section and by postoperative pathology. Thus, all these patients underwent laparoscopic
local resection without extended lymphadenectomy. We conclude that SN biopsy is a useful tool to individualize the operative
procedure, and laparoscopic local resection can be safely performed using SN guidance in selected patients with early gastric
cancer. 相似文献